Phase II-III CRO Benchmarking—Small Pharma Market (5th Ed.)

Phase II-III CRO Benchmarking—Small Pharma Market (5th Ed.)

$2,450.00 – $4,900.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • SITE-WIDE LICENSE (not available for all reports)

    A Site-Wide License allows access to an organization's employees within a single site/location (e.g. New York City office).

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Related products

  • Select options This product has multiple variants. The options may be chosen on the product page

    Late Phase Market Overview and Outlook (2013)

    $4,900.00 – $9,800.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking Report (3rd edition)

    $6,800.00 – $10,200.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    The Phase I Market Overview and Outlook

    $4,900.00 – $7,350.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators

    $4,900.00 – $7,350.00